4.5 Article

The lactate clearance calculated using serum lactate level 6 h after is an important prognostic predictor after extracorporeal cardiopulmonary resuscitation: a single-center retrospective observational study

期刊

JOURNAL OF INTENSIVE CARE
卷 6, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s40560-018-0302-z

关键词

Lactate clearance; Extracorporeal cardiopulmonary resuscitation; Cardiac arrest; In-hospital mortality

资金

  1. Astellas Pharma Inc.
  2. Daiichi-Sankyo Pharma Inc.
  3. MSD K.K
  4. Bayel Pharmaceutical Co., Ltd.
  5. Daiichi Sankyo Co., Ltd.
  6. Dainippon Sumitomo Pharma Co., Ltd.
  7. Kowa Co., Ltd.
  8. Mitsubishi Tanabe Pharma Co.
  9. Nippon Boehringer Ingelheim Co., Ltd.
  10. Novartis Pharma K.K.
  11. Pfizer Japan Inc.
  12. Sanofi-aventis K.K.
  13. Takeda Pharmaceutical Co., Ltd.
  14. Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc.
  15. Otsuka Pharma Ltd.
  16. Teijin Pharma Ltd.

向作者/读者索取更多资源

Background: Serum lactate level can predict clinical outcomes in some critical cases. In the clinical setting, we noted that patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR) and with poor serum lactate improvement often do not recover from cardiopulmonary arrest. Therefore, we investigated the association between lactate clearance and in-hospital mortality in cardiac arrest patients undergoing ECPR. Methods: Serum lactate levels were measured on admission and every hour after starting ECPR. Lactate clearance [(lactate at first measurement - lactate 6 h after)/lactate at first measurement x 100] was calculated 6 h after first serum lactate measurement All patients who underwent ECPR were registered retrospectively using opt-out in our outpatient's segment. Result In this retrospective study, 64 cases were evaluated, and they were classified into two groups according to lactate clearance: high-clearance group, <= 65%; low-clearance group, 5 65%. Surviving discharge rate of high-clearance group (12 cases, 63%) is significantly higher than that of low-clearance group (11 cases, 24%) (p < 0.01). Considering other confounders, lactate clearance was an independent predictor for in-hospital mortality (odds ratio, 7.10; 95% confidence interval, 1.71-29.5; p < 0.01). Both net reclassification improvement (0.64, p < 0.01) and integrated reclassification improvement (0.12, p < 0.01) show that adding lactate clearance on established risk factors improved the predictability of in-hospital mortality. Conclusion: In our study, lactate clearance calculated through arterial blood gas analysis 6 h after ECPR was one of the most important predictors of in-hospital mortality in patients treated with ECPR after cardiac arrest.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据